Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs
Figure 4
Image of FA-TEG-ALA nanoprodrug obtained from nanoparticle tracking analysis (NTA) (a, b) and size distribution of FA-TEG-ALA nanoprodrug as measured by (c) dynamic light scattering (Coulter N4-Plus Submicron Particle Sizer) and (d) NTA. Image (b) is a magnification of a part of the image (a).